Skip to main content
. 2018 Sep 12;92(19):e01087-18. doi: 10.1128/JVI.01087-18

FIG 6.

FIG 6

HCV RNA (A and B) and HCV core antigen (C and D) in Huh7.5 cells treated with ribavirin or ribavirin and guanosine and transfected with ITPA siRNA (A and C) or a negative-control siRNA (B and D). Statistical significance was determined by a t test on logarithmic values (**, P < 0.01; ***, P < 0.001).